Kulke MH, Anthony LB, Bushnell DL et al (2010) NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 39:735–752PubMedCrossRef

Falconi M, Bartsch DK, Eriksson B et al (2012) ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: welldifferentiated pancreatic non functioning tumors. Neuroendocrinology 95:120–134PubMedCrossRef

Norton JA, Fraker DL, Alexander HR et al (1999) Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341:635–644PubMedCrossRef

Norton JA, Jensen RT (2004) Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg 240:757–773PubMedCrossRef

Crippa S, Zerbi A, Boninsegna L et al (2012) Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. Arch Surg Mar 147:261–266CrossRef

Norton JA (1994) Neuroendocrine tumors of the pancreas and duodenum. Curr Probl Surg 31:77–156PubMedCrossRef

Falconi M, Plockinger U, Kwekkenboom DJ et al (2006) Well-differentiated pancreatic nonfunctioning tumors/carcinoma. Neuroendocrinology 84:196–211PubMedCrossRef

Bettini R, Partelli S, Boninsegna L et al (Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery 150:75–82

Falconi M, Zerbi A, Crippa S et al (2010) Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors. Ann Surg Oncol 17:1621–1627PubMedCrossRef

Falconi M, Mantovani W, Crippa S et al (2008) Pancreatic insufficiency after different resections for benign tumors. Br J Surg 95:85–91PubMedCrossRef

Aranha GV, Shoup M (2005) Nonstandard pancreatic resections for unusual lesions. Am J Surg 189:223–228PubMedCrossRef

Boninsegna L, Panzuto F, Partelli S et al (2011) Malignant pancreatic neuroendocrine tumor: Lymph node ratio and Ki67 are predictors of recurrence after curative resections. Eur J Cancer [Epub ahead of print]